The FDA’s Vaccine and Related Biological Products Advisory Committee Meeting of October 22, 2020: An Overhead Reveals Possible Adverse Side Effects of COVID-19 Vaccine

FDA Safety Surveillance of COVID-19 Vaccines :DRAFT Working list of possible adverse event outcomesSubject to change Guillain-Barré syndrome Acute disseminated encephalomyelitis Transverse myelitis Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encepholapathy Convulsions/seizures Stroke Narcolepsy and cataplexy Anaphylaxis Acute myocardial infarction Myocarditis/pericarditis Autoimmune disease Deaths Pregnancy and birth outcomes Other acute demyelinating diseases Non-anaphylactic allergic reactions Thrombocytopenia Disseminated intravascular coagulation Venous thromboembolism ArthritisContinue reading “The FDA’s Vaccine and Related Biological Products Advisory Committee Meeting of October 22, 2020: An Overhead Reveals Possible Adverse Side Effects of COVID-19 Vaccine”